Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Rush University Medical Center
Hypertension
United States
Sponsor: Novartis Pharmaceuticals
Breast Cancer
South Korea
Sponsor: Novartis Pharmaceuticals
Gastro-enteropancreatic Neuroendocrine Tumor
Germany
Sponsor: Novartis Pharmaceuticals
Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer · HR+/HER2- Ductal and Lobular Breast Cancer · Triple Negative Breast Cancer
Canada, Denmark, France, Germany, Israel +1 more
Sponsor: Novartis Pharmaceuticals
Melanoma
Japan
Sponsor: Novartis Pharmaceuticals
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Brazil +36 more
- Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Sjogren Syndrome
United States, Argentina, Australia, Brazil, Bulgaria +21 more
Sponsor: Novartis Pharmaceuticals
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Japan
- Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United Arab Emirates
- A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Completed
Sponsor: Novartis Pharmaceuticals
Huntington Disease
United States, Australia, Austria, Canada, France +6 more
Sponsor: Novartis Pharmaceuticals
Hypertension
Japan
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Japan
- Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)Completed
Sponsor: Novartis Pharmaceuticals
IgA Nephropathy
United States, South Korea, United Kingdom
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Germany
- A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a PlaceboCompleted
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Keratoconjunctivitis Sicca
United States
- Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
KRAS G12C Mutant Solid Tumors · Carcinoma, Non-Small Cell Lung · Carcinoma, Non-Small-Cell Lung · Non-Small Cell Lung Cancer
United States, Belgium, France, Germany, Italy +3 more
- Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia (ITP)
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Switzerland
- 177Lu-DOTATATE for Recurrent MeningiomaRecruiting
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Recurrent Meningioma
Austria, France, Germany, Norway, Spain +1 more
- A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 InhibitorsCompleted
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States
Sponsor: Centre Hospitalier Universitaire, Amiens
Kidney Failure
France
Sponsor: Novartis Pharmaceuticals
Non-Hodgkin Lymphoma
United States, Australia, Austria, Belgium, Brazil +13 more
Sponsor: Novartis Pharmaceuticals
Allergy, Peanut
United States
Sponsor: Novartis Pharmaceuticals
Acute Lymphoblastic Leukemia
United States, Australia, Canada, China, France +7 more
- A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Renal Angiomyolipoma
Taiwan